ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

: Eli Lilly, Boehringer Ingelheim’s Jardiance gets FDA approval for chronic kidney disease
Eli Lilly & Co. LLY and Boehringer Ingelheim said Friday that the U.S. Food and Drug Administration has approved their blockbuster drug Jardiance, already used for heart failure and diabetes, as a treatment for adults with chronic kidney disease. The agenc
Announcement as on 22 September 2023

: Eli Lilly set to dominate obesity drug market into the next decade, analysts say
Eli Lilly & Co. LLY is best positioned to dominate the fast-growing U.S. market for obesity drugs into the 2030s, BMO Capital Markets analysts said in a report late Thursday. Although Novo Nordisk NVO, maker of Ozempic and Wegovy, is likely to maintain sig
Announcement as on 22 September 2023

Are Wall Street Analysts Wrong About Eli Lilly Stock?
Eli Lilly (NYSE: LLY) has been a scorching hot buy in 2023 -- its shares are up more than 55% so far this year. But with the stock trading now at a multiple of 80 times earnings, it certainly isn't cheap. And if you go by Wall Street's price targets, you m
Announcement as on 22 September 2023

: Eli Lilly reports positive results from study of thyroid cancer treatment
Eli Lilly & Co. LLY on Tuesday reported positive results from a study evaluating its targeted therapy Retevmo versus the current standard initial treatments for patients with advanced or metastatic rearranged during transfection (RET)-mutant medullary thyr
Announcement as on 22 August 2023

Eli Lilly Concludes Acquisition Of Sigilon Therapeutics
(RTTNews) - Eli Lilly and Co. (LLY) a biopharmaceutical company, announced on Friday that it has completed the acquisition of Sigilon Therapeutics, Inc. (SGTX).
Announcement as on 14 August 2023

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1327.38
  • 12Day Average: 1293.9
  • 20Day Average: 1246.19
  • 50Day Average: 1197.21
  • 100Day Average: 1187.89
  • 150Day Average: 1121.89
  • 200Day Average: 1092.51

LLY Indicators & signals

Indicator MACD (12,26,9)

1297.95, 1250.96, 32.05
Indicator MACD is in positive zone

Indicator ADX (14)

63.73, 42.33, 9.38
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 1414.92 1382.29 to 1449.68 3.05% 1.39 times
29 Thu Oct 2026 1373.00 1330.00 to 1408.38 6.57% 1.63 times
28 Wed Oct 2026 1288.30 1260.34 to 1299.43 0.53% 1.14 times
27 Tue Oct 2026 1281.52 1270.00 to 1297.92 0.19% 0.47 times
26 Mon Oct 2026 1279.14 1273.73 to 1296.90 0.45% 1.17 times
23 Fri Oct 2026 1273.46 1257.62 to 1307.92 -2.55% 1.27 times
22 Thu Oct 2026 1306.74 1275.10 to 1321.21 2.7% 0.85 times
21 Wed Oct 2026 1272.40 1261.08 to 1279.28 -1.12% 0.52 times
20 Tue Oct 2026 1286.83 1260.17 to 1311.75 3.62% 1.19 times
19 Mon Oct 2026 1241.82 1239.10 to 1259.75 -1.21% 0.42 times
16 Fri Oct 2026 1257.03 1251.25 to 1274.56 0.43% 1.34 times
15 Thu Oct 2026 1251.61 1230.66 to 1275.88 3.55% 2.09 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

 

Back to top